Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 22:22:00 UTC
Update Date2021-09-26 23:17:17 UTC
HMDB IDHMDB0259625
Secondary Accession NumbersNone
Metabolite Identification
Common Name2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-
DescriptionN-(5-{5-[(piperazin-1-yl)methyl]-1,3,4-oxadiazol-2-yl}-2-{[2-(pyridin-4-yl)ethyl]imino}-1,2,3,4-tetrahydropyrimidin-4-ylidene)propan-1-amine belongs to the class of organic compounds known as aminopyrimidines and derivatives. These are organic compounds containing an amino group attached to a pyrimidine ring. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Based on a literature review very few articles have been published on N-(5-{5-[(piperazin-1-yl)methyl]-1,3,4-oxadiazol-2-yl}-2-{[2-(pyridin-4-yl)ethyl]imino}-1,2,3,4-tetrahydropyrimidin-4-ylidene)propan-1-amine. This compound has been identified in human blood as reported by (PMID: 31557052 ). 2,4-pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-n4-propyl-n2-(2-(4-pyridinyl)ethyl)- is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)- is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
SynonymsNot Available
Chemical FormulaC21H29N9O
Average Molecular Weight423.525
Monoisotopic Molecular Weight423.24950659
IUPAC Name5-{5-[(piperazin-1-yl)methyl]-1,3,4-oxadiazol-2-yl}-N4-propyl-N2-[2-(pyridin-4-yl)ethyl]pyrimidine-2,4-diamine
Traditional Name5-[5-(piperazin-1-ylmethyl)-1,3,4-oxadiazol-2-yl]-N4-propyl-N2-[2-(pyridin-4-yl)ethyl]pyrimidine-2,4-diamine
CAS Registry NumberNot Available
SMILES
CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1
InChI Identifier
InChI=1S/C21H29N9O/c1-2-6-24-19-17(20-29-28-18(31-20)15-30-12-10-23-11-13-30)14-26-21(27-19)25-9-5-16-3-7-22-8-4-16/h3-4,7-8,14,23H,2,5-6,9-13,15H2,1H3,(H2,24,25,26,27)
InChI KeyAOGSXPPPFJBSRA-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as aminopyrimidines and derivatives. These are organic compounds containing an amino group attached to a pyrimidine ring. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassDiazines
Sub ClassPyrimidines and pyrimidine derivatives
Direct ParentAminopyrimidines and derivatives
Alternative Parents
Substituents
  • Aminopyrimidine
  • Aralkylamine
  • N-alkylpiperazine
  • 1,4-diazinane
  • Imidolactam
  • Piperazine
  • Pyridine
  • 1,3,4-oxadiazole
  • Azole
  • Heteroaromatic compound
  • Oxadiazole
  • Tertiary aliphatic amine
  • Tertiary amine
  • Secondary aliphatic amine
  • Oxacycle
  • Azacycle
  • Secondary amine
  • Amine
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Organonitrogen compound
  • Organooxygen compound
  • Organic oxygen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP1.47ALOGPS
logP0.43ChemAxon
logS-3.4ALOGPS
pKa (Strongest Acidic)14.8ChemAxon
pKa (Strongest Basic)9.21ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count9ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area116.92 ŲChemAxon
Rotatable Bond Count10ChemAxon
Refractivity134.5 m³·mol⁻¹ChemAxon
Polarizability47.27 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+193.73630932474
DeepCCS[M-H]-191.37830932474
DeepCCS[M-2H]-225.57630932474
DeepCCS[M+Na]+200.80430932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O14198.1Standard polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O13679.0Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O13983.9Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #1CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C3682.8Semi standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #1CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C3725.8Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #1CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C5488.9Standard polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #2CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O13685.0Semi standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #2CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O13733.6Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #2CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O15449.2Standard polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #3CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O13815.7Semi standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #3CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O13798.9Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #3CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O15544.7Standard polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #1CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C3625.8Semi standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #1CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C3498.0Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #1CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C5162.3Standard polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #2CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C3746.8Semi standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #2CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C3723.1Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #2CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C5299.1Standard polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #3CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O13765.0Semi standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #3CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O13726.7Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #3CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O15247.2Standard polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TMS,isomer #1CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C3744.9Semi standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TMS,isomer #1CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C3519.4Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TMS,isomer #1CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C4963.6Standard polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #1CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C3845.6Semi standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #1CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C3916.9Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #1CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C5535.2Standard polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #2CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O13853.2Semi standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #2CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O13922.6Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #2CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O15474.3Standard polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #3CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O14025.6Semi standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #3CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O13988.4Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #3CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O15662.5Standard polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #1CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C3943.8Semi standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #1CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C3910.4Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #1CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C5180.8Standard polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #2CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C4085.0Semi standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #2CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C4076.7Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #2CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C5412.1Standard polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #3CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O14121.3Semi standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #3CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O14077.1Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #3CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O15336.9Standard polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TBDMS,isomer #1CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C4240.9Semi standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TBDMS,isomer #1CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C4112.4Standard non polar33892256
2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TBDMS,isomer #1CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C5071.0Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)- GC-MS (Non-derivatized) - 70eV, Positivesplash10-005d-6309000000-2409773361b40f38a7c52021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)- GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID9692232
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound11517444
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]